Mylan Pharmaceuticals Inc., a Viatris Company, Issues Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection Pens, 100 units/mL (U-100), Due to the Potential of Missing Labels on Some Pens
Summary Company Announcement Date: July 05, 2022 FDA Publish Date: July 06, 2022 Product Type: Drugs Reason for Announcement: Recall...
